<DOC>
	<DOCNO>NCT00723905</DOCNO>
	<brief_summary>Janssen Inc. plan collect data 3000 5000 infliximab infusion per year , start third quarter 2005 . It expect 12 site Remicade Infusion Network ( R.I.N . ) participate . This registry multicentre , prospective , observational program gather analyze data subject treat infliximab .</brief_summary>
	<brief_title>Remicade Infusion Management Program</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Subject good candidate receive infliximab per Product Monograph Subject prescribe infliximab appropriate physician Subject receive infusion community infusion centre . Subject sign approved consent form . Not specify protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Crohn 's Disease , Rheumatoid Arthritis</keyword>
</DOC>